JANUMET Side Effects

7022861-2 | Breast Cancer, Influenza, Post Procedural Complication, Stress Cardiomyopathy, Thyroid Cancer
on Sep 24, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), influenza, post procedural complication, stress cardiomyopathy, thyroid cancer (What is thyroid cancer?). Janumet dosage: . During the same period patient was treated with AVACOR (View Avacor Review and Avacor Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BONIVA (View Boniva Review and Boniva Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), SINGULAIR (View Singulair Review and Singulair Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.

7021485-0 | Abdominal Pain, Decreased Appetite, Hepatitis Toxic, Pyrexia
Patient was taking Janumet (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), decreased appetite, hepatitis toxic, pyrexia on Sep 24, 2010 from NORWAY Additional patient health information: Female patient , 61 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia, hypertension and. Janumet dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ). Patient was hospitalized.

7015615-4 | Adverse Event, Hypertension, Pancreatic Cyst
Adverse event was reported on Sep 20, 2010 by a Female patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 64 years of age, After Janumet was administered, patient had the following side effects: adverse event, hypertension, pancreatic cyst. Patient was hospitalized.

7001883-1 | Atrial Fibrillation, Metabolic Acidosis, Nephrolithiasis
on Sep 15, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), metabolic acidosis, nephrolithiasis. Janumet dosage: . During the same period patient was treated with OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.


6986054-7 | Abdominal Pain, Diarrhoea, Dyspepsia, Lipase Increased, Pancreatitis Chronic
on Sep 13, 2010 Male patient from FRANCE , 61 years of age, weighting 187.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, dyspepsia, lipase increased, pancreatitis chronic. Janumet dosage: . During the same period patient was treated with IRBESARTAN (View Irbesartan Review and Irbesartan Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), LERCANIDIPINE HYDROCHLORIDE (View Lercanidipine Hydrochloride Review and Lercanidipine Hydrochloride Label ).

6986048-1 | Erythema, Oedema Peripheral, Skin Exfoliation, Skin Warm
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: erythema, oedema peripheral, skin exfoliation, skin warm on Sep 13, 2010 from SPAIN Additional patient health information: Female patient , 72 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with TORSEMIDE SODIUM (View Torsemide Sodium Review and Torsemide Sodium Label ), BARNIDIPINE HYDROCHLORIDE (View Barnidipine Hydrochloride Review and Barnidipine Hydrochloride Label ), HYDROCHLOROTHIAZIDE AND OLMESARTAN MEDOXOMIL (View Hydrochlorothiazide And Olmesartan Medoxomil Review and Hydrochlorothiazide And Olmesartan Medoxomil Label ). Patient was hospitalized.

6985573-7 | Transaminases Increased
Adverse event was reported on Sep 10, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 48 years of age, weighting 262.4 lb, Patient experienced the following unwanted or unexpected effects: transaminases increased.

6981102-2 | Dysphagia, Lung Disorder, Lung Neoplasm, Pulmonary Mass, Weight Decreased
on Sep 07, 2010 Female patient from GERMANY , 58 years of age, was diagnosed with autoimmune hepatitis and was treated with Janumet (View Usage). Patient had the following side effects: dysphagia, lung disorder, lung neoplasm, pulmonary mass, weight decreased. Janumet dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

6977103-0 | Lactic Acidosis, Renal Failure Acute
on Sep 07, 2010 Female patient from GERMANY , 73 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: lactic acidosis, renal failure acute. Janumet dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE AND VALSARTAN (View Hydrochlorothiazide And Valsartan Review and Hydrochlorothiazide And Valsartan Label ), ALISKIREN FUMARATE (View Aliskiren Fumarate Review and Aliskiren Fumarate Label ). Patient was hospitalized.

6971137-8 | Metabolic Acidosis
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: metabolic acidosis on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Janumet dosage: .

6965758-6 | Adenocarcinoma
Adverse event was reported on Sep 01, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: ITALY , 65 years of age, Patient had the following side effects: adenocarcinoma. Patient was hospitalized.

6963892-8 | Abdominal Pain Upper, Gastric Cancer
on Aug 30, 2010 Male patient from FRANCE , 61 years of age, weighting 216.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: abdominal pain upper, gastric cancer. Janumet dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ).

6963266-X | Pancreatitis, Weight Decreased
on Aug 30, 2010 Male patient from GERMANY , 66 years of age, weighting 198.4 lb, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia, benign prostatic hyperplasia, ischaemic heart disease prophylaxis, hypertension and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis, weight decreased. Janumet dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6956860-3 | Vascular Purpura
Patient was taking Janumet (View Usage). Patient had the following side effects: vascular purpura on Jul 26, 2010 from FRANCE Additional patient health information: Male patient , 82 years of age, was diagnosed with insulin-requiring type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

6945654-0 | Gastric Disorder, Headache, Nausea
Adverse event was reported on Aug 25, 2010 by a Female patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: AUSTRALIA , 52 years of age, weighting 110.2 lb, After Janumet was administered, patient had the following side effects: gastric disorder, headache (What is headache?), nausea (What is nausea?).

6945648-5 | Diabetes Mellitus, Hyperglycaemia, Oedema Peripheral
on Aug 23, 2010 Female patient from FRANCE , 76 years of age, weighting 132.3 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, hyperglycaemia, oedema peripheral. Janumet dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized.

6934719-5 | Pancreatitis, Weight Decreased
on Aug 18, 2010 Male patient from GERMANY , 65 years of age, weighting 198.4 lb, was diagnosed with type 2 diabetes mellitus, hypercholesterolaemia, benign prostatic hyperplasia, platelet aggregation inhibition, hypertension and was treated with Janumet (View Usage). Patient had the following side effects: pancreatitis, weight decreased. Janumet dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6930614-6 | Lactic Acidosis, Renal Failure Acute
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: lactic acidosis, renal failure acute on Aug 12, 2010 from PORTUGAL Additional patient health information: Female patient , 79 years of age, weighting 121.3 lb, was diagnosed with type 2 diabetes mellitus, oedema, hypertension, dyslipidaemia, atrial fibrillation (What is atrial fibrillation?) and. Janumet dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALISKIREN FUMARATE (View Aliskiren Fumarate Review and Aliskiren Fumarate Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), LERCANIDIPINE HYDROCHLORIDE (View Lercanidipine Hydrochloride Review and Lercanidipine Hydrochloride Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ). Patient was hospitalized.

6929143-5 | Diarrhoea, Feeling Cold, Hypersomnia, Nausea, Pyrexia, Weight Decreased
Adverse event was reported on Aug 13, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: GERMANY , 60 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, feeling cold, hypersomnia, nausea (What is nausea?), pyrexia, weight decreased. Patient was hospitalized.

6926491-X | Pericardial Effusion
on Aug 13, 2010 Male patient from ITALY , 61 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: pericardial effusion. Janumet dosage: . During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), TIMOLOL (View Timolol Review and Timolol Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), METFORMIN (View Metformin Review and Metformin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

6923370-9 | Adenocarcinoma
on Aug 09, 2010 Male patient from ITALY , 65 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: adenocarcinoma. Janumet dosage: . Patient was hospitalized.

6921605-X | Abortion, No Adverse Event
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: abortion (What is abortion?), no adverse event on Aug 04, 2010 from UNITED STATES Additional patient health information: Female patient , 37 years of age, was diagnosed with diabetes mellitus and. Janumet dosage: . During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ).

6919593-5 | Pericardial Effusion
Adverse event was reported on Aug 09, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: ITALY , 61 years of age, Patient had the following side effects: pericardial effusion. Patient was hospitalized.

6914663-X | Thyroid Cancer
on Aug 05, 2010 Male patient from UNITED STATES , 60 years of age, was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: thyroid cancer (What is thyroid cancer?). Janumet dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ).

6914657-4 | Adenocarcinoma Pancreas, Weight Decreased
on Aug 05, 2010 Female patient from UNITED STATES , 65 years of age, weighting 99.21 lb, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: adenocarcinoma pancreas, weight decreased. Janumet dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), VYTORIN (View Vytorin Review and Vytorin Label ), ALTACE (View Altace Review and Altace Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), PROTONIX (View Protonix Review and Protonix Label ), XANAX (View Xanax Review and Xanax Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized and became disabled.

6912340-2 | Abdominal Pain, Diarrhoea
Patient was taking Janumet (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea on Aug 02, 2010 from FRANCE Additional patient health information: Female patient , 66 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with METFORMIN PAMOATE (View Metformin Pamoate Review and Metformin Pamoate Label ). Patient was hospitalized.

6911158-4 | Cholestasis, Diverticulum Intestinal, Hepatitis, Polyp, Thrombocytopenia
Adverse event was reported on Jul 27, 2010 by a Female patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 61 years of age, weighting 136.7 lb, After Janumet was administered, patient had the following side effects: cholestasis, diverticulum intestinal, hepatitis (What is hepatitis?), polyp, thrombocytopenia. Patient was hospitalized.

6906181-X | Diabetes Mellitus Inadequate Control
on Jul 29, 2010 Male patient from FRANCE , 73 years of age, weighting 163.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control. Janumet dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

6902163-2 | Pancreatic Carcinoma
on Jul 28, 2010 Female patient from UNITED STATES , 65 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: pancreatic carcinoma. Janumet dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), VYTORIN (View Vytorin Review and Vytorin Label ), ALTACE (View Altace Review and Altace Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), PROTONIX (View Protonix Review and Protonix Label ), XANAX (View Xanax Review and Xanax Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ).

6902145-0 | Diabetes Mellitus, Hyperglycaemia, Oedema Peripheral
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: diabetes mellitus, hyperglycaemia, oedema peripheral on Jul 26, 2010 from FRANCE Additional patient health information: Female patient , 76 years of age, weighting 132.3 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Janumet dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized.

6897062-9 | Liver Disorder, Liver Function Test Abnormal
Adverse event was reported on Jun 17, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: GERMANY , 59 years of age, Patient experienced the following unwanted or unexpected effects: liver disorder, liver function test abnormal. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ). Patient was hospitalized.

6895291-1 | Diabetes Mellitus Inadequate Control
on Jul 29, 2010 Male patient from FRANCE , 73 years of age, weighting 163.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: diabetes mellitus inadequate control. Janumet dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

6895274-1 | Cholestasis, Hepatitis, Polyp, Thrombocytopenia
on Jul 27, 2010 Female patient from GERMANY , 61 years of age, weighting 136.7 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: cholestasis, hepatitis (What is hepatitis?), polyp, thrombocytopenia. Janumet dosage: . Patient was hospitalized.

6888922-3 | Blister, Rash, Ulcer
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: blister, rash (What is rash?), ulcer (What is ulcer?) on Jul 28, 2010 from GERMANY Additional patient health information: Female patient , 79 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6888149-5 | Diabetes Mellitus Inadequate Control
Adverse event was reported on Jul 28, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 73 years of age, weighting 163.1 lb, Patient had the following side effects: diabetes mellitus inadequate control. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

6888146-X | Food Aversion, Renal Failure Acute, Renal Failure Chronic, Tubulointerstitial Nephritis, Weight Decreased
on Jul 27, 2010 Female patient from GERMANY , 68 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus, hypertension, hyperlipidaemia and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: food aversion, renal failure acute, renal failure chronic, tubulointerstitial nephritis, weight decreased. Janumet dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized and became disabled.

6878468-0 | Thyroid Cancer
on Jul 21, 2010 Male patient from UNITED STATES , 60 years of age, was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: thyroid cancer (What is thyroid cancer?). Janumet dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ).

6878450-3 | Diabetes Mellitus Inadequate Control
Patient was taking Janumet (View Usage). Patient had the following side effects: diabetes mellitus inadequate control on Jul 22, 2010 from FRANCE Additional patient health information: Male patient , 73 years of age, weighting 163.1 lb, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

6877106-0 | Vascular Purpura
Adverse event was reported on Jul 26, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with insulin-requiring type 2 diabetes mellitus and. Location: FRANCE , 82 years of age, After Janumet was administered, patient had the following side effects: vascular purpura. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

6872950-8 | Convulsion
on Jul 20, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Janumet dosage: .

6872944-2 | Convulsion
on Jul 20, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with diabetes mellitus and was treated with Janumet (View Usage). Patient had the following side effects: convulsion. Janumet dosage: . Patient was hospitalized.

6867936-3 | Angioedema, Balance Disorder, Fall
Patient was taking Janumet (View Usage). After Janumet was administered, patient had the following side effects: angioedema, balance disorder, fall (What is fall?) on Jul 22, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 250.4 lb, was diagnosed with diabetes mellitus and. Janumet dosage: 1 Tablet 2x/day Oral 047. Patient was hospitalized.

6863041-0 | Pericardial Effusion
Adverse event was reported on Jul 15, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: ITALY , 61 years of age, Patient experienced the following unwanted or unexpected effects: pericardial effusion. Patient was hospitalized.

6860808-X | Cardiac Failure
on Jul 15, 2010 Male patient from FRANCE , 78 years of age, weighting 180.8 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Janumet (View Usage). Patient had the following side effects: cardiac failure. Janumet dosage: . During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN (View Metformin Review and Metformin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6860678-X | Abdominal Pain, Dyspnoea
on Jul 19, 2010 Male patient from UNITED STATES , 56 years of age, weighting 248.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dyspnoea. Janumet dosage: 50-500 Mg 2 X's Po.

6858477-8 | Gastritis, Renal Failure Acute, Sensation Of Foreign Body, Tubulointerstitial Nephritis
Patient was taking Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: gastritis, renal failure acute, sensation of foreign body, tubulointerstitial nephritis on Jul 15, 2010 from GERMANY Additional patient health information: Male patient , 64 years of age, weighting 205.0 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia, hypertension and. Janumet dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ). Patient was hospitalized and became disabled.

6856651-8 | Aphasia, Coma, Hypoglycaemia
Adverse event was reported on Jul 13, 2010 by a Male patient taking Janumet (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 71 years of age, Patient had the following side effects: aphasia (What is aphasia?), coma, hypoglycaemia. During the same period patient was treated with GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN (View Metformin Review and Metformin Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6856642-7 | Pericardial Effusion
on Jul 15, 2010 Male patient from ITALY , 61 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Janumet (View Usage). After Janumet was administered, patient had the following side effects: pericardial effusion. Janumet dosage: . Patient was hospitalized.

6848424-7 | Renal Failure, Tubulointerstitial Nephritis
on Jul 13, 2010 Female patient from GERMANY , 68 years of age, weighting 127.9 lb, was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia and was treated with Janumet (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, tubulointerstitial nephritis. Janumet dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized and became disabled.

6848423-5 | Pericardial Effusion
Patient was taking Janumet (View Usage). Patient had the following side effects: pericardial effusion on Jul 14, 2010 from ITALY Additional patient health information: Male patient , 61 years of age, was diagnosed with type 2 diabetes mellitus and. Janumet dosage: . Patient was hospitalized.